[Shuoshi Bio: The board of directors rejected the controlling shareholder’s proposal to convene an extraordinary shareholders’ meeting] On October 8, Shuoshi Bio (688399.SH) announced that the 18th meeting of the company’s third board of directors reviewed the “Proposal on Agreeing to the Controlling Shareholder’s Proposal to Convene an Extraordinary Shareholders’ Meeting”. The voting result was 4 votes in favor and 5 votes against, and the motion was not passed. The board of directors did not agree to convene an extraordinary shareholders' meeting. The five opposing directors believed that the validity of the seals on documents related to the controlling shareholder Runkang Biotech was in dispute, and its dissolution lawsuit was under trial. Limited partner Liang Xilin had reported the misappropriation of funds to the public security agency and the case was accepted. Promoting the change at this stage is not conducive to the stability of corporate governance and the protection of the interests of small and medium-sized investors.